Urethral Neoplasms Clinical Trials

Completed

A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function

NCT02665039

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +21 more
Locations: Department of Oncology, Rigshospitalet Copenhagen, Denmark

Department of Oncology, Karolinska University Hospital Stockholm, Sweden

View Trial Details

Completed

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

NCT01282463

Conditions: Adenocarcinoma, Carcinoma, Carcinoma of Renal Pelvis, +21 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sacramento, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States

View all 32 locations

View Trial Details

Completed

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

NCT02300610

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +20 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer

NCT01191892

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom

Wales Cancer Trials Unit Cardiff, Wales, United Kingdom

Ayr Hospital Ayr, United Kingdom

Royal Bournemouth General Hospital Bournemouth, United Kingdom

View all 21 locations

View Trial Details

Completed

Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

NCT01844947

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +21 more
Locations: Department of Oncology, Aarhus University Hospital Aarhus, Denmark

Department of Oncology, Rigshospitalet Copenhagen, Denmark

Department of Oncology, Karolinska University Hospital Stockholm, Sweden

View Trial Details

Completed

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

NCT01089088

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Bristol Haematology and Oncology Centre Bristol, Avon, United Kingdom

Castle Hill Hospital Cottingham, East Yorkshire, United Kingdom

Royal Bournemouth Hospital Bournemouth, England, United Kingdom

Churchill Hospital Oxford, Oxfordshire, United Kingdom

View all 16 locations

View Trial Details

Completed

Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants

NCT00900276

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +21 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium

NCT01090466

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom

View Trial Details

Completed

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

NCT00003704

Conditions: Adnexal Diseases, Anus Diseases, Anus Neoplasms, +56 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

CCOP - Carle Cancer Center Urbana, Illinois, United States

CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States

CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States

View all 18 locations

View Trial Details

Completed

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00083213

Conditions: Adenocarcinoma, Adnexal Diseases, Burkitt Lymphoma, +81 more
Locations: Memorial Sloan - Kettering Cancer Center New York, United States

View Trial Details

Urethral Neoplasms

Urethral Neoplasms trial results

Related conditions